Acute liver failure natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
 
(2 intermediate revisions by 2 users not shown)
Line 3: Line 3:
{{CMG}} {{AE}} {{HS}}
{{CMG}} {{AE}} {{HS}}
==Overview==
==Overview==
Acute liver failure is a sudden and severe loss of liver function with evidence of [[encephalopathy]] and [[coagulopathy]] with elevated [[prothrombin time (PT)]] and [[INR|(INR)]] in a person without preexisting liver disease. The commonly used time duration for an acute liver disease is < 26 weeks. Acute liver failure can be hyperacute, acute or subacute depending upon how long the patient has signs and symptoms of liver failure. If left untreated, patients with acute liver failure can eventually progress to develop [[confusion]], [[Comatose|comatose state]], and death. Common complications of acute liver failure are [[hepatic encephalopathy]], [[cerebral edema]], [[coagulopathy]], a [[systemic inflammatory response syndrome]], [[acute renal failure]] and [[Pulmonary failure|acute pulmonary failure]]. The important factors in determining the prognosis of acute liver failure include patients' age, the severity of [[encephalopathy]] and the underlying cause of acute liver failure. The commonly used [[prognostic]] indicators to predict [[mortality]] in patients with acute liver failure and to identify patients who are likely to benefit from [[liver transplantation]] include kings college criteria ( use for liver transplantation ) and model for end-stage liver disease (MELD) score (to predict mortality in patients with chronic and acute liver disease).  
Acute liver failure is a sudden and severe loss of liver function with evidence of [[encephalopathy]] and [[coagulopathy]] with elevated [[prothrombin time (PT)]] and [[INR|(INR)]] in a person without preexisting liver disease. The commonly used time duration for an acute liver disease is < 26 weeks. Acute liver failure can be hyperacute, acute or subacute depending upon how long the patient has signs and symptoms of liver failure. If left untreated, patients with acute liver failure can eventually progress to develop [[confusion]], [[Comatose|comatose state]], and death. Common complications of acute liver failure are [[hepatic encephalopathy]], [[cerebral edema]], [[coagulopathy]], a [[systemic inflammatory response syndrome]], [[acute renal failure]] and [[Pulmonary failure|acute pulmonary failure]]. The important factors in determining the prognosis of acute liver failure include patients' age, the severity of [[encephalopathy]] and the underlying cause of acute liver failure. The commonly used [[prognostic]] indicators to predict [[mortality]] in patients with acute liver failure and to identify patients who are likely to benefit from [[liver transplantation]] include kings college criteria ( used for [[liver transplantation]] ) and [[Model for end stage liver disease|model for end-stage liver disease]] ([[MELD]]) score (to predict mortality in patients with chronic and acute liver disease).  
==Natural History==
==Natural History==
Acute liver failure is a sudden and severe loss of liver function with evidence of [[encephalopathy]] and [[coagulopathy]] with elevated [[prothrombin time (PT)]] and [[INR|(INR)]] in a person without preexisting liver disease. The commonly used time duration for an acute liver disease is < 26 weeks.<ref name="pmid17608778">{{cite journal| author=Bower WA, Johns M, Margolis HS, Williams IT, Bell BP| title=Population-based surveillance for acute liver failure. | journal=Am J Gastroenterol | year= 2007 | volume= 102 | issue= 11 | pages= 2459-63 | pmid=17608778 | doi=10.1111/j.1572-0241.2007.01388.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17608778  }} </ref>
Acute liver failure is a sudden and severe loss of liver function with evidence of [[encephalopathy]] and [[coagulopathy]] with elevated [[prothrombin time (PT)]] and [[INR|(INR)]] in a person without preexisting liver disease. The commonly used time duration for an acute liver disease is < 26 weeks.<ref name="pmid17608778">{{cite journal| author=Bower WA, Johns M, Margolis HS, Williams IT, Bell BP| title=Population-based surveillance for acute liver failure. | journal=Am J Gastroenterol | year= 2007 | volume= 102 | issue= 11 | pages= 2459-63 | pmid=17608778 | doi=10.1111/j.1572-0241.2007.01388.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17608778  }} </ref>
* Acute liver failure can be hyperacute, acute or subacute depending upon how long the patient has signs and symptoms of liver failure.
* Acute liver failure can be hyperacute, acute or subacute depending upon how long the patient has signs and symptoms of liver failure.
* The natural history of acute liver failure depends on the etiology but generally, [[cerebral edema]] mainly presents in hyperacute or acute liver failure, whereas [[Renal failure|renal shutdown]] and [[portal hypertension]] are the main concerns in the subacute liver failure.
* The natural history of acute liver failure depends on the etiology but generally, [[cerebral edema]] mainly presents in hyperacute or acute liver failure, whereas [[Renal failure|renal shutdown]] and [[portal hypertension]] are the main concerns in the subacute liver failure.
* If left untreated, patients with acute liver failure may initially having nonspecific symptoms such as [[anorexia]], [[fatigue]], nausea or vomiting, diffuse or right upper quadrant abdominal pain or [[jaundice]] and can eventually progress to develop [[confusion]] and the [[comatose]] state and death.  A systemic inflammatory response syndrome may also develop. [[Acute renal failure]] occurs in up to 50% of cases. The condition can also worsen to the point of causing [[Hemodynamics|hemodynamic]] and [[cardiovascular]] compromise.
* If left untreated, patients with acute liver failure may initially having nonspecific symptoms such as [[anorexia]], [[fatigue]], [[Nausea and vomiting case study one|nausea and vomiting]], diffuse or [[Right upper quadrant abdominal pain resident survival guide|right upper quadrant abdominal pain]] or [[jaundice]] and can eventually progress to develop [[confusion]] and the [[comatose]] state and death.  A [[systemic inflammatory response syndrome]] may also develop. [[Acute renal failure]] occurs in up to 50% of cases. The condition can also worsen to the point of causing [[Hemodynamics|hemodynamic]] and [[cardiovascular]] compromise.
* The timely recognition and treatment of some of the causes of acute liver failure can reverse the condition and may improve the patient's prognosis. The timely evaluation can also help in identifying patients who may require [[Liver transplantation|liver transplantation.]]  
* The timely recognition and treatment of some of the causes of acute liver failure can reverse the condition and may improve the patient's prognosis. The timely evaluation can also help in identifying patients who may require [[Liver transplantation|liver transplantation.]]  
* In [[acetaminophen]] toxicity patients, the time duration between acetaminophen ingestion and treatment with [[acetylcysteine]] greatly influence the outcome.
* In [[acetaminophen toxicity]] patients, the time duration between [[acetaminophen]] ingestion and treatment with [[acetylcysteine]] greatly influence the outcome.


==Complications==
==Complications==
Complications that can develop as a result of acute liver failure are:<ref name="pmid20196116">{{cite journal| author=Kumar R, Shalimar. Bhatia V, Khanal S, Sreenivas V, Gupta SD et al.| title=Antituberculosis therapy-induced acute liver failure: magnitude, profile, prognosis, and predictors of outcome. | journal=Hepatology | year= 2010 | volume= 51 | issue= 5 | pages= 1665-74 | pmid=20196116 | doi=10.1002/hep.23534 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20196116  }} </ref><ref name="pmid9250851">{{cite journal |vauthors=Riordan SM, Williams R |title=Treatment of hepatic encephalopathy |journal=N. Engl. J. Med. |volume=337 |issue=7 |pages=473–9 |year=1997 |pmid=9250851 |doi=10.1056/NEJM199708143370707 |url=}}</ref><ref name="pmid8305063">{{cite journal |vauthors=Lee WM |title=Acute liver failure |journal=N. Engl. J. Med. |volume=329 |issue=25 |pages=1862–72 |year=1993 |pmid=8305063 |doi=10.1056/NEJM199312163292508 |url=}}</ref><ref name="pmid8303321">{{cite journal |vauthors=Muñoz SJ |title=Difficult management problems in fulminant hepatic failure |journal=Semin. Liver Dis. |volume=13 |issue=4 |pages=395–413 |year=1993 |pmid=8303321 |doi= |url=}}</ref><ref>{{cite journal |author=Hazell AS, Butterworth RF |title=Hepatic encephalopathy: An update of pathophysiologic mechanisms |journal=Proc. Soc. Exp. Biol. Med. |volume=222 |issue=2 |pages=99-112 |year=1999 |pmid=10564534 |doi=}}</ref><ref>{{cite journal |author=Larsen FS, Wendon J |title=Brain edema in liver failure: basic physiologic principles and management |journal=Liver Transpl. |volume=8 |issue=11 |pages=983-9 |year=2002 |pmid=12424710 |doi=10.1053/jlts.2002.35779}}</ref>.<ref>{{cite journal |author=Armstrong IR, Pollok A, Lee A |title=Complications of intracranial pressure monitoring in fulminant hepatic failure |journal=Lancet |volume=341 |issue=8846 |pages=690-1 |year=1993 |pmid=8095592 |doi=}}</ref><ref>{{cite journal |author=Schmidt LE, Larsen FS |title=Prognostic implications of [[Lactate|hyperlactatemia]], multiple organ failure, and systemic inflammatory response syndrome in patients with acetaminophen-induced acute liver failure |journal=Crit. Care Med. |volume=34 |issue=2 |pages=337-43 |year=2006 |pmid=16424712 |doi=}}</ref><ref>{{cite journal |author=Harry R, Auzinger G, Wendon J |title=The clinical importance of adrenal insufficiency in acute hepatic dysfunction |journal=Hepatology |volume=36 |issue=2 |pages=395-402 |year=2002 |pmid=12143048 |doi=10.1053/jhep.2002.34514}}</ref>. There is also abnormal [[oxygen]] transport and utilization. Although delivery of oxygen to the tissues is adequate, there is a decrease in tissue oxygen uptake, resulting in [[tissue]] [[hypoxia]] and lactic acidosis<ref>{{cite journal |author=Bihari D, Gimson AE, Waterson M, Williams R |title=Tissue hypoxia during fulminant hepatic failure |journal=Crit. Care Med. |volume=13 |issue=12 |pages=1034-9 |year=1985 |pmid=3933911 |doi=}}</ref><ref>{{cite journal |author=Trewby PN, Warren R, Contini S, ''et al'' |title=Incidence and pathophysiology of pulmonary edema in fulminant hepatic failure |journal=Gastroenterology |volume=74 |issue=5 Pt 1 |pages=859-65 |year=1978 |pmid=346431 |doi=}}</ref>.
Complications that can develop as a result of acute liver failure are:<ref name="pmid20196116">{{cite journal| author=Kumar R, Shalimar. Bhatia V, Khanal S, Sreenivas V, Gupta SD et al.| title=Antituberculosis therapy-induced acute liver failure: magnitude, profile, prognosis, and predictors of outcome. | journal=Hepatology | year= 2010 | volume= 51 | issue= 5 | pages= 1665-74 | pmid=20196116 | doi=10.1002/hep.23534 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20196116  }} </ref><ref name="pmid9250851">{{cite journal |vauthors=Riordan SM, Williams R |title=Treatment of hepatic encephalopathy |journal=N. Engl. J. Med. |volume=337 |issue=7 |pages=473–9 |year=1997 |pmid=9250851 |doi=10.1056/NEJM199708143370707 |url=}}</ref><ref name="pmid8305063">{{cite journal |vauthors=Lee WM |title=Acute liver failure |journal=N. Engl. J. Med. |volume=329 |issue=25 |pages=1862–72 |year=1993 |pmid=8305063 |doi=10.1056/NEJM199312163292508 |url=}}</ref><ref name="pmid8303321">{{cite journal |vauthors=Muñoz SJ |title=Difficult management problems in fulminant hepatic failure |journal=Semin. Liver Dis. |volume=13 |issue=4 |pages=395–413 |year=1993 |pmid=8303321 |doi= |url=}}</ref><ref>{{cite journal |author=Hazell AS, Butterworth RF |title=Hepatic encephalopathy: An update of pathophysiologic mechanisms |journal=Proc. Soc. Exp. Biol. Med. |volume=222 |issue=2 |pages=99-112 |year=1999 |pmid=10564534 |doi=}}</ref><ref>{{cite journal |author=Larsen FS, Wendon J |title=Brain edema in liver failure: basic physiologic principles and management |journal=Liver Transpl. |volume=8 |issue=11 |pages=983-9 |year=2002 |pmid=12424710 |doi=10.1053/jlts.2002.35779}}</ref><ref>{{cite journal |author=Armstrong IR, Pollok A, Lee A |title=Complications of intracranial pressure monitoring in fulminant hepatic failure |journal=Lancet |volume=341 |issue=8846 |pages=690-1 |year=1993 |pmid=8095592 |doi=}}</ref><ref>{{cite journal |author=Schmidt LE, Larsen FS |title=Prognostic implications of [[Lactate|hyperlactatemia]], multiple organ failure, and systemic inflammatory response syndrome in patients with acetaminophen-induced acute liver failure |journal=Crit. Care Med. |volume=34 |issue=2 |pages=337-43 |year=2006 |pmid=16424712 |doi=}}</ref><ref>{{cite journal |author=Harry R, Auzinger G, Wendon J |title=The clinical importance of adrenal insufficiency in acute hepatic dysfunction |journal=Hepatology |volume=36 |issue=2 |pages=395-402 |year=2002 |pmid=12143048 |doi=10.1053/jhep.2002.34514}}</ref><ref>{{cite journal |author=Bihari D, Gimson AE, Waterson M, Williams R |title=Tissue hypoxia during fulminant hepatic failure |journal=Crit. Care Med. |volume=13 |issue=12 |pages=1034-9 |year=1985 |pmid=3933911 |doi=}}</ref><ref>{{cite journal |author=Trewby PN, Warren R, Contini S, ''et al'' |title=Incidence and pathophysiology of pulmonary edema in fulminant hepatic failure |journal=Gastroenterology |volume=74 |issue=5 Pt 1 |pages=859-65 |year=1978 |pmid=346431 |doi=}}</ref>
* [[Cerebral edema]]
* [[Cerebral edema]]
* [[Encephalopathy]]
* [[Encephalopathy]]
Line 19: Line 19:
* [[Renal failure]]
* [[Renal failure]]
* [[Renal failure]]  
* [[Renal failure]]  
* [[Systemic inflammatory response]]
* [[Systemic inflammatory response syndrome|Systemic inflammatory response]]
* [[Metabolic derrangements]]
* Metabolic derrangements  
* [[Pulmonary complications]]
* [[Pulmonary]] complications


==Prognosis==
==Prognosis==
* The important factors in determining the prognosis of acute liver failure include patients' age, the severity of [[encephalopathy]] and the underlying cause of acute liver failure.<ref name="pmid9635624">{{cite journal |vauthors=Dhiman RK, Seth AK, Jain S, Chawla YK, Dilawari JB |title=Prognostic evaluation of early indicators in fulminant hepatic failure by multivariate analysis |journal=Dig. Dis. Sci. |volume=43 |issue=6 |pages=1311–6 |year=1998 |pmid=9635624 |doi= |url=}}</ref><ref name="pmid8792311">{{cite journal |vauthors=Huo TI, Wu JC, Sheng WY, Chan CY, Hwang SJ, Chen TZ, Lee SD |title=Prognostic factor analysis of fulminant and subfulminant hepatic failure in an area endemic for hepatitis B |journal=J. Gastroenterol. Hepatol. |volume=11 |issue=6 |pages=560–5 |year=1996 |pmid=8792311 |doi= |url=}}</ref><ref name="pmid8175127">{{cite journal |vauthors=Takahashi Y, Kumada H, Shimizu M, Tanikawa K, Kumashiro R, Omata M, Ehata T, Tsuji T, Ukida M, Yasunaga M |title=A multicenter study on the prognosis of fulminant viral hepatitis: early prediction for liver transplantation |journal=Hepatology |volume=19 |issue=5 |pages=1065–71 |year=1994 |pmid=8175127 |doi= |url=}}</ref><ref name="pmid7875687">{{cite journal |vauthors=Lake JR, Sussman NL |title=Determining prognosis in patients with fulminant hepatic failure: when you absolutely, positively have to know the answer |journal=Hepatology |volume=21 |issue=3 |pages=879–82 |year=1995 |pmid=7875687 |doi= |url=}}</ref><ref name="pmid8445211">{{cite journal |vauthors=Pauwels A, Mostefa-Kara N, Florent C, Lévy VG |title=Emergency liver transplantation for acute liver failure. Evaluation of London and Clichy criteria |journal=J. Hepatol. |volume=17 |issue=1 |pages=124–7 |year=1993 |pmid=8445211 |doi= |url=}}</ref><ref name="pmid22885329">{{cite journal |vauthors=Rutherford A, King LY, Hynan LS, Vedvyas C, Lin W, Lee WM, Chung RT |title=Development of an accurate index for predicting outcomes of patients with acute liver failure |journal=Gastroenterology |volume=143 |issue=5 |pages=1237–43 |year=2012 |pmid=22885329 |pmc=3480539 |doi=10.1053/j.gastro.2012.07.113 |url=}}</ref>
* The important factors in determining the prognosis of acute liver failure include patients' age, the severity of [[encephalopathy]] and the underlying cause of acute liver failure.<ref name="pmid9635624">{{cite journal |vauthors=Dhiman RK, Seth AK, Jain S, Chawla YK, Dilawari JB |title=Prognostic evaluation of early indicators in fulminant hepatic failure by multivariate analysis |journal=Dig. Dis. Sci. |volume=43 |issue=6 |pages=1311–6 |year=1998 |pmid=9635624 |doi= |url=}}</ref><ref name="pmid8792311">{{cite journal |vauthors=Huo TI, Wu JC, Sheng WY, Chan CY, Hwang SJ, Chen TZ, Lee SD |title=Prognostic factor analysis of fulminant and subfulminant hepatic failure in an area endemic for hepatitis B |journal=J. Gastroenterol. Hepatol. |volume=11 |issue=6 |pages=560–5 |year=1996 |pmid=8792311 |doi= |url=}}</ref><ref name="pmid8175127">{{cite journal |vauthors=Takahashi Y, Kumada H, Shimizu M, Tanikawa K, Kumashiro R, Omata M, Ehata T, Tsuji T, Ukida M, Yasunaga M |title=A multicenter study on the prognosis of fulminant viral hepatitis: early prediction for liver transplantation |journal=Hepatology |volume=19 |issue=5 |pages=1065–71 |year=1994 |pmid=8175127 |doi= |url=}}</ref><ref name="pmid7875687">{{cite journal |vauthors=Lake JR, Sussman NL |title=Determining prognosis in patients with fulminant hepatic failure: when you absolutely, positively have to know the answer |journal=Hepatology |volume=21 |issue=3 |pages=879–82 |year=1995 |pmid=7875687 |doi= |url=}}</ref><ref name="pmid8445211">{{cite journal |vauthors=Pauwels A, Mostefa-Kara N, Florent C, Lévy VG |title=Emergency liver transplantation for acute liver failure. Evaluation of London and Clichy criteria |journal=J. Hepatol. |volume=17 |issue=1 |pages=124–7 |year=1993 |pmid=8445211 |doi= |url=}}</ref><ref name="pmid22885329">{{cite journal |vauthors=Rutherford A, King LY, Hynan LS, Vedvyas C, Lin W, Lee WM, Chung RT |title=Development of an accurate index for predicting outcomes of patients with acute liver failure |journal=Gastroenterology |volume=143 |issue=5 |pages=1237–43 |year=2012 |pmid=22885329 |pmc=3480539 |doi=10.1053/j.gastro.2012.07.113 |url=}}</ref>
Several [[prognostic]] scoring systems to predict [[mortality]] in patients with acute liver failure and to identify patients who are likely to benefit from liver transplantation include:
 
*[[King's College Criteria]] ( most widely use for [[liver transplantation]])
* Several [[prognostic]] scoring systems to predict [[mortality]] in patients with acute liver failure and to identify patients who are likely to benefit from liver transplantation include:
*[[Model for End-Stage Liver Disease]] (MELD) score (use to predict mortality in patients with chronic and acute liver disease)
 
*Sequential Organ Failure Assessment (SOFA score)
**[[King's College Criteria]] (mostly used for [[liver transplantation]])
*Clichy criteria
**[[Model for End-Stage Liver Disease]] ([[MELD]]) score (used to predict mortality in patients with chronic and acute liver disease)
*Acute Liver Failure Study Group (ALFSG) index
**Sequential Organ Failure Assessment (SOFA score)
**Clichy criteria
**Acute Liver Failure Study Group (ALFSG) index


==References==
==References==

Latest revision as of 20:54, 18 December 2017

Acute liver failure Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Acute Liver Failure from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Acute liver failure natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Acute liver failure natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Acute liver failure natural history, complications and prognosis

CDC on Acute liver failure natural history, complications and prognosis

Acute liver failure natural history, complications and prognosis in the news

Blogs on Acute liver failure natural history, complications and prognosis

Directions to Hospitals Treating Acute liver failure

Risk calculators and risk factors for Acute liver failure natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Husnain Shaukat, M.D [2]

Overview

Acute liver failure is a sudden and severe loss of liver function with evidence of encephalopathy and coagulopathy with elevated prothrombin time (PT) and (INR) in a person without preexisting liver disease. The commonly used time duration for an acute liver disease is < 26 weeks. Acute liver failure can be hyperacute, acute or subacute depending upon how long the patient has signs and symptoms of liver failure. If left untreated, patients with acute liver failure can eventually progress to develop confusion, comatose state, and death. Common complications of acute liver failure are hepatic encephalopathy, cerebral edema, coagulopathy, a systemic inflammatory response syndrome, acute renal failure and acute pulmonary failure. The important factors in determining the prognosis of acute liver failure include patients' age, the severity of encephalopathy and the underlying cause of acute liver failure. The commonly used prognostic indicators to predict mortality in patients with acute liver failure and to identify patients who are likely to benefit from liver transplantation include kings college criteria ( used for liver transplantation ) and model for end-stage liver disease (MELD) score (to predict mortality in patients with chronic and acute liver disease).

Natural History

Acute liver failure is a sudden and severe loss of liver function with evidence of encephalopathy and coagulopathy with elevated prothrombin time (PT) and (INR) in a person without preexisting liver disease. The commonly used time duration for an acute liver disease is < 26 weeks.[1]

Complications

Complications that can develop as a result of acute liver failure are:[2][3][4][5][6][7][8][9][10][11][12]

Prognosis

  • The important factors in determining the prognosis of acute liver failure include patients' age, the severity of encephalopathy and the underlying cause of acute liver failure.[13][14][15][16][17][18]
  • Several prognostic scoring systems to predict mortality in patients with acute liver failure and to identify patients who are likely to benefit from liver transplantation include:

References

  1. Bower WA, Johns M, Margolis HS, Williams IT, Bell BP (2007). "Population-based surveillance for acute liver failure". Am J Gastroenterol. 102 (11): 2459–63. doi:10.1111/j.1572-0241.2007.01388.x. PMID 17608778.
  2. Kumar R, Shalimar. Bhatia V, Khanal S, Sreenivas V, Gupta SD; et al. (2010). "Antituberculosis therapy-induced acute liver failure: magnitude, profile, prognosis, and predictors of outcome". Hepatology. 51 (5): 1665–74. doi:10.1002/hep.23534. PMID 20196116.
  3. Riordan SM, Williams R (1997). "Treatment of hepatic encephalopathy". N. Engl. J. Med. 337 (7): 473–9. doi:10.1056/NEJM199708143370707. PMID 9250851.
  4. Lee WM (1993). "Acute liver failure". N. Engl. J. Med. 329 (25): 1862–72. doi:10.1056/NEJM199312163292508. PMID 8305063.
  5. Muñoz SJ (1993). "Difficult management problems in fulminant hepatic failure". Semin. Liver Dis. 13 (4): 395–413. PMID 8303321.
  6. Hazell AS, Butterworth RF (1999). "Hepatic encephalopathy: An update of pathophysiologic mechanisms". Proc. Soc. Exp. Biol. Med. 222 (2): 99–112. PMID 10564534.
  7. Larsen FS, Wendon J (2002). "Brain edema in liver failure: basic physiologic principles and management". Liver Transpl. 8 (11): 983–9. doi:10.1053/jlts.2002.35779. PMID 12424710.
  8. Armstrong IR, Pollok A, Lee A (1993). "Complications of intracranial pressure monitoring in fulminant hepatic failure". Lancet. 341 (8846): 690–1. PMID 8095592.
  9. Schmidt LE, Larsen FS (2006). "hyperlactatemia". Crit. Care Med. 34 (2): 337–43. PMID 16424712.
  10. Harry R, Auzinger G, Wendon J (2002). "The clinical importance of adrenal insufficiency in acute hepatic dysfunction". Hepatology. 36 (2): 395–402. doi:10.1053/jhep.2002.34514. PMID 12143048.
  11. Bihari D, Gimson AE, Waterson M, Williams R (1985). "Tissue hypoxia during fulminant hepatic failure". Crit. Care Med. 13 (12): 1034–9. PMID 3933911.
  12. Trewby PN, Warren R, Contini S; et al. (1978). "Incidence and pathophysiology of pulmonary edema in fulminant hepatic failure". Gastroenterology. 74 (5 Pt 1): 859–65. PMID 346431.
  13. Dhiman RK, Seth AK, Jain S, Chawla YK, Dilawari JB (1998). "Prognostic evaluation of early indicators in fulminant hepatic failure by multivariate analysis". Dig. Dis. Sci. 43 (6): 1311–6. PMID 9635624.
  14. Huo TI, Wu JC, Sheng WY, Chan CY, Hwang SJ, Chen TZ, Lee SD (1996). "Prognostic factor analysis of fulminant and subfulminant hepatic failure in an area endemic for hepatitis B". J. Gastroenterol. Hepatol. 11 (6): 560–5. PMID 8792311.
  15. Takahashi Y, Kumada H, Shimizu M, Tanikawa K, Kumashiro R, Omata M, Ehata T, Tsuji T, Ukida M, Yasunaga M (1994). "A multicenter study on the prognosis of fulminant viral hepatitis: early prediction for liver transplantation". Hepatology. 19 (5): 1065–71. PMID 8175127.
  16. Lake JR, Sussman NL (1995). "Determining prognosis in patients with fulminant hepatic failure: when you absolutely, positively have to know the answer". Hepatology. 21 (3): 879–82. PMID 7875687.
  17. Pauwels A, Mostefa-Kara N, Florent C, Lévy VG (1993). "Emergency liver transplantation for acute liver failure. Evaluation of London and Clichy criteria". J. Hepatol. 17 (1): 124–7. PMID 8445211.
  18. Rutherford A, King LY, Hynan LS, Vedvyas C, Lin W, Lee WM, Chung RT (2012). "Development of an accurate index for predicting outcomes of patients with acute liver failure". Gastroenterology. 143 (5): 1237–43. doi:10.1053/j.gastro.2012.07.113. PMC 3480539. PMID 22885329.

Template:WH Template:WS